Boundless Bio earnings were -$64.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BOLD earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$23.7M, up 74.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BOLD reported annual earnings of -$58.2M, with -11% growth. The next BOLD earnings date is Nov 4, 2026.
On BOLD's earnings call on Aug 11, 2026, Boundless Bio (NASDAQ: BOLD) reported Q2 2026 earnings per share (EPS) of -$1.06, up 51.43% year over year. Total BOLD earnings for the quarter were -$23.69 million. In the same quarter last year, Boundless Bio's earnings per share (EPS) was -$0.70.
The next BOLD earnings date is Nov 4, 2026. Add BOLD to your watchlist to be reminded of Boundless Bio's next earnings date.
What was BOLD's earnings growth in the past year?
As of Boundless Bio's earnings date in Aug 11, 2026, Boundless Bio's earnings has grown year over year. BOLD earnings in the past year totalled -$64.01 million.
Is Boundless Bio profitable or losing money?
As of the last Boundless Bio earnings report, Boundless Bio is currently losing money. Boundless Bio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$64.01 million, a 0.59% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.